Lo Yi-Ching, Tsou Huei-Hsia, Lin Rong-Jyh, Wu Deng-Chyang, Wu Bin-Nan, Lin Young-Tso, Chen Ing-Jun
Department and post graduate institute of Pharmacology, College of Medicine, Kaohsiung Medical University, 100 Shin-Chuan 1st road, Kaohsiung 807, Taiwan.
Life Sci. 2005 Jan 7;76(8):931-44. doi: 10.1016/j.lfs.2004.10.009.
The vasorelaxation activities of MCPT, a newly synthesized xanthine derivative, were investigated in this study. In phenylephrine (PE)-precontracted rat aortic rings with intact endothelium, MCPT caused a concentration-dependent relaxation, which was inhibited by endothelium removed. This relaxation was also reduced by the presence of nitric oxide synthase inhibitor Nomega-nitro-L-arginine methylester (L-NAME, 100 microM), soluble guanylyl cyclase (sGC) inhibitors methylene blue (10 microM), 1 H-[1,2,4] oxidazolol [4,3-a] quinoxalin-1-one (ODQ, 1 microM), adenylyl cyclase (AC) blocker SQ 22536 (100 microM), ATP-sensitive K+ channel blocker (KATP) glibenclamide (1 microM), a Ca2+ activated K+ channels blocker tetraethylammonium (TEA, 10 mM) and a voltage-dependent potassium channels blocker 4-aminopyridine (4-AP, 100 microM). The vasorelaxant effects of MCPT together with IBMX (0.5 microM) had an additive action. In PE-preconstricted endothelium-denuded aortic rings, the vasorelaxant effects of MCPT were attenuated by pretreatments with glibenclamide (1 microM), SQ 22536 (100 microM) or ODQ (1 microM), respectively. MCPT enhanced cAMP-dependent vasodilator isoprenaline- and NO donor/cGMP-dependent vasodilator sodium nitroprusside-induced relaxation activities in endothelium-denuded aortic rings. In A-10 cell and washed human platelets, MCPT induced a concentration-dependent increase in intracellular cyclic GMP and cyclic AMP levels. In phosphodiesterase assay, MCPT displayed inhibition effects on PDE 3, PDE 4 and PDE 5. The inhibition % were 52 +/- 3.9, 32 +/- 2.6 and 8 +/- 1.1 respectively. The Western blot analysis on HUVEC indicated that MCPT increased the expression of eNOS. It is concluded that the vasorelaxation by MCPT may be mediated by the inhibition of phosphodiesterase, stimulation of NO/sGC/ cGMP and AC/cAMP pathways, and the opening of K+ channels.
本研究对新合成的黄嘌呤衍生物MCPT的血管舒张活性进行了研究。在苯肾上腺素(PE)预收缩的、内皮完整的大鼠主动脉环中,MCPT引起浓度依赖性舒张,去除内皮后该舒张作用受到抑制。一氧化氮合酶抑制剂Nω-硝基-L-精氨酸甲酯(L-NAME,100 μM)、可溶性鸟苷酸环化酶(sGC)抑制剂亚甲蓝(10 μM)、1H-[1,2,4]恶二唑并[4,3-a]喹喔啉-1-酮(ODQ,1 μM)、腺苷酸环化酶(AC)阻断剂SQ 22536(100 μM)、ATP敏感性钾通道(KATP)阻断剂格列本脲(1 μM)、钙激活钾通道阻断剂四乙铵(TEA,10 mM)以及电压依赖性钾通道阻断剂4-氨基吡啶(4-AP,100 μM)的存在也会降低这种舒张作用。MCPT与IBMX(0.5 μM)共同作用时的血管舒张效应具有相加作用。在PE预收缩的去内皮主动脉环中,格列本脲(1 μM)、SQ 22536(100 μM)或ODQ(1 μM)预处理分别减弱了MCPT的血管舒张作用。MCPT增强了去内皮主动脉环中cAMP依赖性血管舒张剂异丙肾上腺素以及NO供体/ cGMP依赖性血管舒张剂硝普钠诱导的舒张活性。在A-10细胞和洗涤后的人血小板中,MCPT引起细胞内环状GMP和环状AMP水平的浓度依赖性升高。在磷酸二酯酶测定中,MCPT对磷酸二酯酶3、磷酸二酯酶4和磷酸二酯酶5显示出抑制作用。抑制率分别为52±3.9、32±2.6和8±1.1。对人脐静脉内皮细胞(HUVEC)的蛋白质免疫印迹分析表明,MCPT增加了内皮型一氧化氮合酶(eNOS)的表达。结论是,MCPT的血管舒张作用可能是通过抑制磷酸二酯酶、刺激NO/sGC/ cGMP和AC/cAMP途径以及开放钾通道介导的。